2019 has been a year of significant progress in systemic sclerosis (SSc) research and treatments. Here are some of the highlight Key Treatment Advances First Scleroderma Specific Drug Approved: The [...]
As you may know, the Scleroderma Education Project is a 501c3 non-profit organization, so as you think about charitable giving for the year, please consider an end-of-year donation to the [...]
Scleroderma News just published a story about a new research paper in Clinical Rheumatology that shows a link between abnormal whole blood viscosity (WBV) and pulmonary artery hypertension (PAH): Scleroderma News: Abnormal WBV and [...]
Therapeutic plasma exchange (TPE/therapeutic apheresis) is a process in which most of the plasma (the liquid part of blood) is replaced by a substitute fluid such as sterilized albumin in [...]
Scl-70 antibody testing can be done by a number of different methods. Historically, Scl-70 antibody testing was mostly done by a technique called double immunodiffusion (ID), which is considered to [...]
Shingrix is a new shingles vaccine that is known to be much more effective than the previous generation shingles vaccine (Zostavax). However, a new article in the newsletter MedPage Today [...]
The 20th annual Scleroderma Foundation national patient education conference was held over this past weekend in Philadelphia. As always, it was excellent and very informative. Attendance was over 700 people, a [...]
This past March, after we announced that the research paper “Therapeutic Plasma Exchange for the Treatment of Systemic Sclerosis: A Comprehensive Review and Analysis” had been published in the Journal [...]
We are pleased to announce that the Scleroderma Education Project has just started a new YouTube educational channel. Our first video is an overview of the research literature on therapeutic plasma [...]
Scleroderma News just ran a feature story on our newly published research paper titled “Therapeutic Plasma Exchange for the Treatment of Systemic Sclerosis: A Comprehensive Review and Analysis”. The paper [...]
